119 related articles for article (PubMed ID: 8016979)
1. [Clinical drug research in Denmark--as effective, harmless and cheap as possible].
Højgaard L
Ugeskr Laeger; 1994 Feb; 156(6):784-6. PubMed ID: 8016979
[No Abstract] [Full Text] [Related]
2. A new colonialism?--Conducting clinical trials in India.
Nundy S; Gulhati CM
N Engl J Med; 2005 Apr; 352(16):1633-6. PubMed ID: 15843665
[No Abstract] [Full Text] [Related]
3. Cutting the cost of drug development?
Rawlins MD
Nat Rev Drug Discov; 2004 Apr; 3(4):360-4. PubMed ID: 15060531
[No Abstract] [Full Text] [Related]
4. Clinical research: outlook from industry.
Echols R
Clin Perform Qual Health Care; 1996; 4(2):113-4. PubMed ID: 10156942
[No Abstract] [Full Text] [Related]
5. [The roles and responsibilities of the pharmaceutical industry].
Dejgaard A; Thomsen MK
Ugeskr Laeger; 2003 Apr; 165(16):1676-9. PubMed ID: 12756829
[TBL] [Abstract][Full Text] [Related]
6. [Pharmaceutical industry and clinical drug research].
Huttunen MO
Duodecim; 2000; 116(24):2813-5. PubMed ID: 12077886
[No Abstract] [Full Text] [Related]
7. Clinical trials in India: balancing economic opportunity with the public health context.
Dandona L
Natl Med J India; 2006; 19(2):57-9. PubMed ID: 16756189
[No Abstract] [Full Text] [Related]
8. America's other drug problem: how the drug industry distorts medicine and politics.
Relman AS; Angell M
New Repub; 2002 Dec; 227(25):27-41. PubMed ID: 12561803
[No Abstract] [Full Text] [Related]
9. Industry-sponsored pharmaceutical trials and research ethics boards: are they cloaked in too much secrecy?
Ferris LE
CMAJ; 2002 May; 166(10):1279-80. PubMed ID: 12041844
[No Abstract] [Full Text] [Related]
10. [Drug development costs are overstated by the industry].
Jeppsson A
Lakartidningen; 2006 Mar 1-7; 103(9):663-4; discussion 664. PubMed ID: 16583545
[No Abstract] [Full Text] [Related]
11. Brand-name drug companies fail to meet R&D commitments.
Kondro W
CMAJ; 2006 Aug; 175(4):344. PubMed ID: 16908891
[No Abstract] [Full Text] [Related]
12. Who pays what in drug development.
Love J
Nature; 1999 Jan; 397(6716):202. PubMed ID: 9930689
[No Abstract] [Full Text] [Related]
13. European researchers up in arms over new clinical trials edict.
Bosch X
Nat Med; 2003 Nov; 9(11):1336. PubMed ID: 14595413
[No Abstract] [Full Text] [Related]
14. The right to a trial: Should dying patients have access to experimental drugs?
Groopman J
New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
[No Abstract] [Full Text] [Related]
15. New clinical trials policy at FDA.
Vastag B
Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196
[No Abstract] [Full Text] [Related]
16. [Clinical research and pharmaceutical industry. A relationship with advantages and disadvantages].
ten Cate JW; Büller HR
Ned Tijdschr Geneeskd; 1999 Jul; 143(30):1572-6. PubMed ID: 10443284
[TBL] [Abstract][Full Text] [Related]
17. India's drug tests.
Padma TV
Nature; 2005 Jul; 436(7050):485. PubMed ID: 16049471
[No Abstract] [Full Text] [Related]
18. The price of pills. Does it really take $897 million for a new therapy?
Ezzell C
Sci Am; 2003 Jul; 289(1):25. PubMed ID: 12840941
[No Abstract] [Full Text] [Related]
19. [The GCP directive--consequences for clinical drug research].
Gluud CN
Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
[TBL] [Abstract][Full Text] [Related]
20. Piercing the veil of corporate secrecy about clinical trials.
Lemmens T
Hastings Cent Rep; 2004; 34(5):14-8. PubMed ID: 15553393
[No Abstract] [Full Text] [Related]
[Next] [New Search]
